mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |